Literature DB >> 12081764

Contribution of grade, vascular invasion and age to outcome in clinically localized renal cell carcinoma.

D F R Griffiths1, A Verghese, A Golash, H G Kynaston, P N Matthews, A J L Hart, J B Court.   

Abstract

OBJECTIVE: To determine the relative prognostic importance of microvascular invasion in apparently localized renal cell carcinoma (RCC). PATIENTS AND METHODS: A retrospective clinical and pathological review was conducted of 176 consecutive patients identified from pathology records who had a nephrectomy for RCC with a median follow-up of 44 months. Vascular invasion was recorded and categorized by the level of microvascular invasion (MVI), renal vein invasion (RVI) and inferior vena cava invasion (IVCI). Tumour type, grade and size were also assessed. These variables were assessed by univariate and multivariate analysis to determine their effect on disease-free survival.
RESULTS: In the univariate analysis tumour size, grade, vascular invasion and young age each predicted reduced disease-free survival. On multivariate analysis for all 176 patients, grade, vascular invasion and young age were the significant independent predictors of reduced disease-free survival. In a subgroup of 149 patients from whom those with very high risk determinants were excluded (those with grade 4 tumours and/or IVCI) most of the risk of metastasis could be accounted for by vascular invasion and young age alone (MVI vs no vascular invasion, hazard ratio 3.18, 95% confidence interval 1.29-7.84; RVI vs no vascular invasion 2.41, 0.989-5.89; and age per year 0.963, 0.94-0.992).
CONCLUSIONS: Grade, vascular invasion and young age are the main independent predictors of relapse in clinically localized RCC after nephrectomy. For most patients, who do not have very high risk indicators, the main adverse predictors are vascular invasion and young age. These findings are important when selecting patients for trials of adjuvant therapy and have implications for pathological staging.

Entities:  

Mesh:

Year:  2002        PMID: 12081764     DOI: 10.1046/j.1464-410x.2002.02661.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  11 in total

1.  Microvascular invasion as a prognostic indicator in renal cell carcinoma: a systematic review and meta-analysis.

Authors:  Hai Huang; Xiu-Wu Pan; Yi Huang; Dan-Feng Xu; Xin-Gang Cui; Lin Li; Yi Hong; Lu Chen; Yi Gao; Lei Yin
Journal:  Int J Clin Exp Med       Date:  2015-07-15

2.  Evaluation of a protocol for examining nephrectomy specimens with renal cell carcinoma.

Authors:  D F R Griffiths; N Nind; C J O'Brien; M Rashid; A Verghese
Journal:  J Clin Pathol       Date:  2003-05       Impact factor: 3.411

Review 3.  Best Practice No 180. Nephrectomy for renal tumour; dissection guide and dataset.

Authors:  S Fleming; D F R Griffiths
Journal:  J Clin Pathol       Date:  2005-01       Impact factor: 3.411

4.  Assessment of the Cardiff nephrectomy cut-up protocol with total blocking of the renal sinus: effect on tumour staging and practical issues.

Authors:  E J Soilleux; I S D Roberts
Journal:  J Clin Pathol       Date:  2006-11       Impact factor: 3.411

5.  Differences in peritumoral pseudocapsule characteristics according to clinicopathological factors in clinical T1a renal tumors.

Authors:  Myong Kim; Woo Suk Choi; Chang Wook Jeong; Ja Hyeon Ku; Hyeon Hoe Kim; Kyung Chul Moon; Cheol Kwak
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

6.  Phospho-4e-BP1 and eIF4E overexpression synergistically drives disease progression in clinically confined clear cell renal cell carcinoma.

Authors:  Lee Campbell; Bharat Jasani; David Fr Griffiths; Mark Gumbleton
Journal:  Am J Cancer Res       Date:  2015-08-15       Impact factor: 6.166

Review 7.  Conservative management of renal masses in the elderly: our experience.

Authors:  Herman S Fernando; Sudhir Duvuru; Simon J Hawkyard
Journal:  Int Urol Nephrol       Date:  2007-01-25       Impact factor: 2.266

8.  Adjuvant and neoadjuvant small-molecule targeted therapy in high-risk renal cell carcinoma.

Authors:  A Kapoor; A Gharajeh; A Sheikh; J Pinthus
Journal:  Curr Oncol       Date:  2009-05       Impact factor: 3.677

9.  Combined expression of caveolin-1 and an activated AKT/mTOR pathway predicts reduced disease-free survival in clinically confined renal cell carcinoma.

Authors:  L Campbell; B Jasani; K Edwards; M Gumbleton; D F R Griffiths
Journal:  Br J Cancer       Date:  2008-02-19       Impact factor: 7.640

10.  Caveolin-1 overexpression predicts poor disease-free survival of patients with clinically confined renal cell carcinoma.

Authors:  L Campbell; M Gumbleton; D F R Griffiths
Journal:  Br J Cancer       Date:  2003-11-17       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.